Related Experiment Video
Updated: Aug 29, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Cardiac disease in chronic kidney disease: current understandings and opportunities for change
1St Paul's Hospital, University of British Columbia, Vancouver, Canada. alevin@providencehealth.bc.ca
Insights
Cardiovascular disease (CVD) is common in chronic kidney disease (CKD) patients due to traditional and novel risk factors. Understanding the interplay between CVD and CKD is crucial for improving patient outcomes.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Cardiovascular disease (CVD) is highly prevalent in all stages of chronic kidney disease (CKD), including pre-dialysis, dialysis, and post-transplant.
- Mild kidney dysfunction is increasingly recognized as a significant risk factor for cardiac disease.
- Both traditional and non-traditional risk factors contribute to the high burden of CVD in CKD patients.
Purpose of the Study:
- To review the current understanding of the relationship between cardiovascular disease and chronic kidney disease.
- To highlight the impact of novel risk factors such as anemia, mineral metabolism disorders, inflammation, and cytokine activation on CVD outcomes in CKD.
- To emphasize the pathophysiological interplay between CVD and CKD.
Main Methods:
- Review of publications over the last decade focusing on CVD in CKD populations.
- Analysis of cross-sectional and prospective observational studies.
- Synthesis of current knowledge on risk factors and their impact on patient outcomes.
Main Results:
- Anemia and mineral metabolism disorders are key factors impacting CVD outcomes in CKD.
- Inflammation and cytokine activation are implicated in the pathophysiology linking CKD and CVD.
- Despite improved understanding, no clinical trials have yet confirmed the benefits of interventions targeting these novel risk factors.
Conclusions:
- CVD and CKD are interconnected conditions with shared pathophysiological processes.
- Further research, particularly clinical trials, is needed to validate interventions targeting novel risk factors for CVD in CKD patients.
- A comprehensive understanding of this interplay is essential for improving overall patient prognosis.
Abstract:
Cardiovascular disease (CVD) is prevalent in patients with kidney disease: in populations prior to dialysis, on dialysis and after transplantation. Publications over the last decade have focused on this, and more recently, patients with cardiac disease are now recognized as being at increased risk in the presence of even mild kidney dysfunction. The presence of both traditional and non-traditional risk factors contributes to this overwhelming burden of cardiovascular disease in patients with chronic kidney disease (CKD). Recent studies have focused on the impact of anemia and disorders of mineral metabolism on CVD outcomes, in the context of inflammation and evidence of cytokine activation. Cross-sectional and prospective observational studies have led to improved understanding, and generated novel hypotheses. To date, no clinical trial has determined the positive impact of interventions targeted at these novel risk factors. This overview describes the current state of knowledge and emphasizes the interplay between CVD and CKD as two aspects of a set of pathophysiological processes, which impact on patient outcomes.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
